MedPath

Sahara Tilmicosin 10% w/w Powder

Registration Number: MAL16010026HA

Approved
Approval ID

c6318dcd8fb4e88c

Registration Number

MAL16010026HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

20.00 mcg/mLAvailable
Package Size: 20.00 mcg/mL
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

TILMICOSIN PHOSPHATEActive
Monograph: tilmicosin phosphate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sahara Tilmicosin 10% w/w Powder - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform